Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Cash & Equivalents (2010 - 2026)

Talphera (TLPH) posted Cash & Equivalents of $17.1 million for Q2 2026, down 19.1% on a QoQ basis from $21.1 million in Q1 2026, and up 151.45% year-over-year from $6.8 million in Q2 2025.

Analysis

Talphera (TLPH) Cash & Equivalents (2010 - 2026) Analysis & Trends

Talphera has reported Cash & Equivalents for 17 years, with the latest figure at $17.1 million in Q2 2026.

  • On a quarterly basis, Cash & Equivalents rose 151.45% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $17.1 million, a 151.45% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 129.96% from the prior year.
  • Cash & Equivalents was $17.1 million for Q2 2026 at Talphera, down from $21.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $39.3 million in Q1 2022, with the low at $5.4 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $16.5 million, with a median of $15.5 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Cash & Equivalents tumbled 73.46% in 2023, then surged 291.76% in 2026.
  • Over 5 years, Cash & Equivalents stood at $20.8 million in 2022, then tumbled by 54.83% to $9.4 million in 2023, then declined by 5.52% to $8.9 million in 2024, then surged by 129.96% to $20.4 million in 2025, then retreated by 16.22% to $17.1 million in 2026.
  • The last three Cash & Equivalents figures came in at $17.1 million (Q2 2026), $21.1 million (Q1 2026), and $20.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 6.14 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.46 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 3.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 1.72 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.71 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 1.29 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.25 Bn
10 Talphera 92.90 Mn 92.90 Mn - 17.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.08 Mn
Mar 31, 2026 21.11 Mn
Dec 31, 2025 20.38 Mn
Sep 30, 2025 21.29 Mn
Jun 30, 2025 6.79 Mn
Mar 31, 2025 5.39 Mn
Dec 31, 2024 8.86 Mn
Sep 30, 2024 11.12 Mn
Jun 30, 2024 14.02 Mn
Mar 31, 2024 18.58 Mn
Dec 31, 2023 9.38 Mn
Sep 30, 2023 13.39 Mn
Jun 30, 2023 7.41 Mn
Mar 31, 2023 13.35 Mn
Dec 31, 2022 20.77 Mn
Sep 30, 2022 20.93 Mn
Jun 30, 2022 27.92 Mn
Mar 31, 2022 39.35 Mn
Dec 31, 2021 51.63 Mn
Sep 30, 2021 8.27 Mn